Skip to main content
Equibles

BARCLAYS PLC

Position in PRLD — Prelude Therapeutics Inc

CIK 312069 LONDON, X0
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$77,439
+$48,027 QoQ
Shares Held
14,529
+68.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 75 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. PRLD ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in PRLD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $77,439 14,529
2026-03-31 $29,412 8,600
2025-12-31 $24,945 8,602
2025-09-30 $12,544 8,712
2025-06-30 $6,959 8,602
2025-03-31 $17,775 23,145
2024-12-31 $37,960 29,773
2024-09-30 $56,231 27,165
2024-06-30 $55,629 14,601
2024-03-31 $96,634 20,387
2023-12-31 $130,346 30,526
2023-09-30 $41,146 13,316
2023-06-30 $27,234 6,052
2023-03-31 $58,835 10,322
2022-12-31 $548,576 90,824
2022-09-30 $34,159 5,168
2022-06-30 $21,193 4,060
2022-03-31 $40,551 5,877